Humoral immune response to human papillomavirus infection.

Suppr

超能文献

作者信息

Carter J J, Galloway D A

机构信息

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104-2092, USA.

出版信息

Clin Dermatol. 1997 Mar-Apr;15(2):249-59. doi: 10.1016/s0738-081x(97)00068-0.

DOI:10.1016/s0738-081x(97)00068-0

PMID:9167909

Abstract

摘要

相似文献

Humoral immune response to human papillomavirus infection.

Clin Dermatol. 1997 Mar-Apr;15(2):249-59. doi: 10.1016/s0738-081x(97)00068-0.

Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.比较肛门生殖器癌各部位的人乳头瘤病毒16型和18型L1血清学。

Cancer Res. 2001 Mar 1;61(5):1934-40.

Human papillomavirus infection in women. Special aspects of infectious diseases in women.女性人乳头瘤病毒感染。女性传染病的特殊方面。

Clin Dermatol. 1997 Jan-Feb;15(1):67-79. doi: 10.1016/s0738-081x(96)00111-3.

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.人乳头瘤病毒感染预防性和治疗性疫苗的进展

Expert Rev Vaccines. 2003 Jun;2(3):381-9. doi: 10.1586/14760584.2.3.381.

Immunologic responses to human papillomavirus infection.对人乳头瘤病毒感染的免疫反应。

Obstet Gynecol Clin North Am. 1996 Sep;23(3):625-39.

Neth J Med. 2008 Mar;66(3):98-102.

[Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].[利用新型真实人乳头瘤病毒抗原（病毒样颗粒）对妇科患者样本中人乳头瘤病毒6型抗体进行的特异性血清学研究]

Gynakol Geburtshilfliche Rundsch. 1995;35 Suppl 1:25-31. doi: 10.1159/000272559.

Human papillomavirus vaccine development.人乳头瘤病毒疫苗的研发。

Australas J Dermatol. 1998 Nov;39 Suppl 1:S8-10.

Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.尖锐湿疣或新的无症状感染患者中抗人乳头瘤病毒6型抗体产生情况的前瞻性研究

J Med Virol. 1995 Aug;46(4):368-74. doi: 10.1002/jmv.1890460413.

Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.用具有人乳头瘤病毒16型次要衣壳蛋白L2上交叉中和表位的肽对小鼠进行鼻腔免疫可引发全身和粘膜抗体。

Vaccine. 2001 Jan 8;19(11-12):1496-502. doi: 10.1016/s0264-410x(00)00367-4.

引用本文的文献

Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.针对宫颈癌高危非接种女性血清和宫颈阴道 IgG 对 α7 和 α9 HPV 的免疫应答：对补种预防性 HPV 疫苗接种的启示。

PLoS One. 2020 May 18;15(5):e0233084. doi: 10.1371/journal.pone.0233084. eCollection 2020.

Natural history of human papillomavirus and vaccinations in men: A literature review.男性人乳头瘤病毒的自然史及疫苗接种：文献综述

Health Sci Rep. 2019 Mar 12;2(5):e118. doi: 10.1002/hsr2.118. eCollection 2019 May.

Serodiagnosis for tumor viruses.肿瘤病毒的血清学诊断

Semin Oncol. 2015 Apr;42(2):191-206. doi: 10.1053/j.seminoncol.2014.12.024. Epub 2014 Dec 31.

Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China.中国天津市生殖器疣女性患者的 HPV 型别检测和中和抗体。

Virol Sin. 2010 Feb;25(1):8-17. doi: 10.1007/s12250-010-3078-4. Epub 2010 Feb 12.

Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?人乳头瘤病毒的预处理血清阳性对头颈部癌症有预后意义吗？

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2087-96. doi: 10.1158/1055-9965.EPI-08-0054.

Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.根据组织学、人乳头瘤病毒（HPV）类型和HPV辅助因子，沙眼衣原体抗体与宫颈癌风险的相关性

Int J Cancer. 2007 Feb 1;120(3):650-5. doi: 10.1002/ijc.22325.

Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.口腔液中人类乳头瘤病毒特异性抗体状态适度反映了人类免疫缺陷病毒阳性个体的血清状态。

Clin Diagn Lab Immunol. 2003 May;10(3):431-8. doi: 10.1128/cdli.10.3.431-438.2003.

Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.人乳头瘤病毒感染：流行病学、诊断及治疗的最新进展

Curr Infect Dis Rep. 2000 Feb;2(1):18-24. doi: 10.1007/s11908-000-0083-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验